http://www.astrazeneca.se/Aktieagare/2010-02-25daily1.0http://www.astrazeneca.se/Aktieagare/Aktieinformation/2009-11-02daily0.8http://www.astrazeneca.se/Aktieagare/Aktieinformation/Aterkop/2008-12-09daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2010-01-28daily0.8http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2009/2009-11-26daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2008/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2007/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2006/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2005/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2004/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2003/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2002/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Ekonomiska_rapporter/2001/2009-04-16daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2009-08-14daily0.8http://www.astrazeneca.se/Aktieagare/Presentationer/2009/2009-08-14daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2008/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2007/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2006/2009-08-12daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2005/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2004/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2003/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2002/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2001/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/2000/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/Presentationer/1999/2009-04-17daily0.6http://www.astrazeneca.se/Aktieagare/arsredovisningar/2009-04-17daily0.8http://www.astrazeneca.se/forskning/2009-10-29daily1.0http://www.astrazeneca.se/forskning/lakemedel/2009-03-23daily0.8http://www.astrazeneca.se/forskning/lakemedel/ytterligare_information2008-10-14monthly0.5http://www.astrazeneca.se/forskning/forskningsomraden/2009-03-23daily0.8http://www.astrazeneca.se/forskning/Globala_specialistcentra/2008-07-02daily0.8http://www.astrazeneca.se/Career/2009-10-29daily1.0http://www.astrazeneca.se/Career/Varfor_jobba_hos_oss/2009-03-24daily0.8http://www.astrazeneca.se/Career/Att_jobba_hos_oss/2009-03-24daily0.8http://www.astrazeneca.se/Career/Att_jobba_hos_oss/Vi_kan_erbjuda_dig/2009-03-24daily0.6http://www.astrazeneca.se/Career/Att_jobba_hos_oss/Vi_kan_erbjuda_dig/Beloningssystem/2009-03-24daily0.4http://www.astrazeneca.se/Career/Att_jobba_hos_oss/Vi_kan_erbjuda_dig/wellBeing/2010-03-01daily0.4http://www.astrazeneca.se/Career/Att_jobba_hos_oss/Vi_kan_erbjuda_dig/3178086/2008-08-22daily0.4http://www.astrazeneca.se/Career/Att-soka-jobb-hos-oss/2010-01-19daily0.8http://www.astrazeneca.se/Career/Utvecklas-hos-oss/2009-03-24daily0.8http://www.astrazeneca.se/Career/Utvecklas-hos-oss/FinanceGraduateProgramme/2010-02-23daily0.6http://www.astrazeneca.se/Career/Utvecklas-hos-oss/Karriarvagar/2008-07-01daily0.6http://www.astrazeneca.se/Career/Utvecklas-hos-oss/Karriarvagar/researchAndDevelopment/2008-07-14daily0.4http://www.astrazeneca.se/Career/Utvecklas-hos-oss/Karriarvagar/Operations/2008-07-14daily0.4http://www.astrazeneca.se/Career/Utvecklas-hos-oss/Karriarvagar/ISMO/2008-07-14daily0.4http://www.astrazeneca.se/Career/For_dig_som_ar_student/2010-03-04daily0.8http://www.astrazeneca.se/Career/For_dig_som_ar_student/Sommarjobb/2010-01-11daily0.6http://www.astrazeneca.se/Career/For_dig_som_ar_student/Till_hogskolestudenten/2010-01-27daily0.6http://www.astrazeneca.se/Career/For_dig_som_ar_student/Traffa_oss/2010-02-11daily0.6http://www.astrazeneca.se/Career/For_dig_som_ar_student/FAQ/2010-01-19daily0.6http://www.astrazeneca.se/Nyheter/pressReleases/2008-07-15daily0.8http://www.astrazeneca.se/om_oss/2009-10-29daily1.0http://www.astrazeneca.se/om_oss/StyrelseAstraZenecaAB/2009-12-16daily0.8http://www.astrazeneca.se/om_oss/styrelseochforetagsledning/2009-11-16daily0.8http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/2009-08-11daily0.8http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/Forskning/2009-04-30daily0.6http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/Forskning/lund/2009-04-30daily0.4http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/Forskning/Molndal/2009-04-30daily0.4http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/Forskning/Sodertalje/2009-04-30daily0.4http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/Marknadsforing/2009-08-11daily0.6http://www.astrazeneca.se/om_oss/verksamheten-i-Sverige/Marknadsforing/AstraZeneca-Nordic/2009-08-11daily0.4http://www.astrazeneca.se/om_oss/varhistoria/2009-04-08daily0.8http://www.astrazeneca.se/Post-doktorstipendier/2009-10-29daily1.0http://www.astrazeneca.se/Pressrum/2009-10-29daily1.0http://www.astrazeneca.se/Pressrum/Aktiviteter/2008-12-10daily0.8http://www.astrazeneca.se/Pressrum/Bildbank/2009-05-06daily0.8http://www.astrazeneca.se/Pressrum/Pressmeddelanden/2009-04-02daily0.8http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Andningsvagar-och-inflammation/2009-04-23daily0.6http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Cancer/2009-04-23daily0.6http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Hjarta-karl/2008-10-28daily0.6http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Infektion/2009-04-23daily0.6http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Mage-tarm/2008-10-28daily0.6http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Neurovetenskap/2009-04-15daily0.6http://www.astrazeneca.se/Pressrum/Pressmeddelanden/Egenvard/2008-11-17daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009-04-08daily0.8http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/2010-01-07daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/AstraZeneca-and-Dako?itemId=81962082010-01-19monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Haiti?itemId=85037302010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Avtal-om-patenttvister?itemId=80190372010-01-07monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/AZ_minskar_antalet_enheter?itemId=86996312010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/uppgorelse-brittiska-skattemyndigheten?itemId=85847542010-02-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Rigel-Pharmaceuticals?itemId=85036692010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/AstraZenecas-helarsresultat-2009?itemId=85036982010-03-02monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/ny-indikation-for-Crestor?itemId=85036922010-02-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Sommarjobb?itemId=85037452010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Nya-antibiotika?itemId=85037392010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/HORIZON-III?itemId=87485852010-03-08monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/tillverkning-blodtrycksmedicin?itemId=85037242010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Cancerlakemedlet-Iressa?itemId=86997372010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/AstraZeneca-Merck?itemId=86996202010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2010/Nebunette?itemId=85036852010-03-02monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/2010-01-07daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/PersonerMedAstmaMarSamre?itemId=57794702009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca_and_Merck?itemId=60445942009-06-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/avslutar-licenssamarbete?itemId=64281472009-07-09monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-WDD?itemId=74390622009-11-13monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5567875?itemId=55679812009-04-22monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787521111?itemId=55825942009-04-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Registreringsansokning-Zactima?itemId=73196662009-10-28monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787521112111111?itemId=57179922009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-klimatarbete?itemId=69613052010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-forvarvar-Novexel-samarbetet-Forest-Laboratories?itemId=79038642010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5567875211?itemId=55823392009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/ADHD-program?itemId=64167042009-07-09monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca_miljokonferens?itemId=61128632009-06-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-klinisk-forskning?itemId=61719142010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Registreringsansokan-Vimovo-EU?itemId=72349142009-10-19monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/2052011?itemId=55310292009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-klimatsmartast?itemId=62131992010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-registreringsansokan-Brilinta-USA?itemId=75047032009-11-19monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Seroquel_XR?itemId=60195822009-05-29monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/FasIII_studieBRILINTA?itemId=58377322009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787512?itemId=55682822009-04-22monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5567875211121111?itemId=55831542009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca_Trilipix?itemId=61124602009-06-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca_Certriad?itemId=61125602009-06-10monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Forskningssamarbete?itemId=64152982010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/nasta-generations-antibiotikum?itemId=67277502009-08-12monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-Nektar?itemId=70307982009-09-21monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-Targacept-avtal-TC-5214?itemId=76503932010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530634?itemId=55306342009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787522?itemId=57693402009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5893611?itemId=58943452010-01-15monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/55678752?itemId=55687132009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/svensk-forskning?itemId=71435142010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/rosa-steget?itemId=67051552010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/AstraZeneca-lakemedelsforetag?itemId=71497132010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/55678752111211111?itemId=55832222009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/delarsrapport-q3?itemId=73272842010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/delarsrapport-januari-juni-09?itemId=66109212010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Forskningslokaler_Molndal?itemId=61190062009-06-05monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/553083111?itemId=55677612009-04-22monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/PN400?itemId=63526642009-07-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/55678752111?itemId=55825342009-04-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Behandling-minskar-risk-aterfall-brostcancer-kostnadseffektiv?itemId=75456432009-11-26monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/BRO-priset-2009?itemId=70802202010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Faslodex-brostcancer?itemId=70620312009-09-25monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787521?itemId=55688862009-04-22monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5567875211121?itemId=55828422009-04-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Crestor-aldre-patienter?itemId=68884032009-08-31monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/55308311?itemId=55308592009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787521112?itemId=55827252009-04-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Crestor_heterozygot?itemId=72141052009-10-19monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530831?itemId=55308432009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Patenttvist_Seroquel?itemId=70794212009-09-28monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Hjart-karlhandelser-kvinnor-rosuvastatin?itemId=74990572009-11-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Diabetes_galopperande_sjukdom?itemId=58649362009-05-13monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Patenttvist_PULMICORT_RESPULES?itemId=59839362009-05-25monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/205201?itemId=55306972009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/EU-konferens-lakemedel?itemId=75069102010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Fas3-studie-ticagrelor?itemId=68813062009-08-30monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530854?itemId=55308542009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/ONGLYZA-typ-2-diabetes?itemId=66301722009-08-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/FDA-godkanner-Seroquel-unga-schizofreni-bipolar-mani?itemId=76616672009-12-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/FDA-godkanner-Seroquel-XR-tillaggsbehandling-depression?itemId=76613312009-12-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530831111?itemId=55683162009-04-22monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/FDA_accepterar_Vimovo_ansokan?itemId=68885212009-09-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Seroquel?itemId=61700642009-06-11monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530481?itemId=55304812009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Fas-3-resultat-dapagliflozin?itemId=71085182009-10-06monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787511?itemId=55681562009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/datorer-till-sydafrika?itemId=67973762010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/sommarforskarskolan?itemId=62322852010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Iressa-sjukdomsfri-overlevnad?itemId=67970692009-11-13monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/IRESSA?itemId=63519362009-07-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Jan_Lundberg_lamnar_AZ?itemId=74654322010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Gothia-Forum-motesplats?itemId=69582042010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Kombinationsbehandling-KOL?itemId=70028272009-09-14monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Kombinationsbehandling?itemId=59862952009-05-25monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5567875211121111111?itemId=57180202009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/behandling_brost_aggstockscancer?itemId=60437002009-06-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530364?itemId=55303642009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/motavizumab_FDA?itemId=79050812009-12-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Nexium_godkant?itemId=57782112009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/NY_cancersite?itemId=61432922009-06-10monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Lindrar_symtom_refluxsjukdom?itemId=60748112009-06-03monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Effekt-utan-fler-biverkningar-brostcancer?itemId=77612012009-12-11monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/PLATO-studien-ticagrelor?itemId=70603492009-09-25monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/studier-ticagrelor-fordjupad-forstaelse-verkan?itemId=75002032009-11-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/55678752111211?itemId=55828802009-05-18monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Onglyza_godkant_Europa?itemId=71352772009-10-06monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Onglyza-Europa-typ-2diabetes?itemId=63062362009-06-26monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/vimovo?itemId=72359902009-10-19monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Positivt-FDA-Crestor-JUPITER-studien?itemId=78173492009-12-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Refluxstipendiet_2009?itemId=61425592009-06-08monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/55678751?itemId=55679952009-04-22monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Seroquel_bipolardepression?itemId=59414332009-05-19monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Seroquel-XR-Depot-EU?itemId=70861952009-09-29monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Studie_Onglyza?itemId=71352832009-10-06monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Symbicort_godkant_Japan?itemId=72125172009-10-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Ticagrelor?itemId=74767032009-11-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Zactima_sjukdomsfri_overlevnad?itemId=60436642009-06-01monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Trainees-AstraZeneca?itemId=69058102010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/5530803?itemId=55308032009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Gyllene_Spirometern_2009?itemId=71449802010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/Underlag-FDAs-radgivande-kommitte-Crestor-FDAs-hemsida?itemId=77656072009-12-11monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/556787521112111?itemId=55830072009-05-16monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2009/www-astrazeneca-se-basta-sajt?itemId=72595982010-03-04monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/2010-01-07daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20582?itemId=51384852009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20798?itemId=51383332009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137846?itemId=51378462009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138153?itemId=51381532009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20512?itemId=51384542009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137489?itemId=51374892009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137499?itemId=51374992009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137493?itemId=51374932009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137503?itemId=51375032009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137505?itemId=51375052009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137511?itemId=51375112009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137501?itemId=51375012009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20784?itemId=51383172009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138157?itemId=51381572009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20992?itemId=51381902009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20584?itemId=51384712009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20445?itemId=51385222009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20954?itemId=51382722009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20998?itemId=51381982009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137509?itemId=51375092009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20938?itemId=51383382009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20940?itemId=51382912009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137634?itemId=51376342009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137481?itemId=51374812009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137812?itemId=51378122009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138159?itemId=51381592009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/207541?itemId=55273492009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/2067611?itemId=55295402009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20518?itemId=51384782009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137631?itemId=51376312009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20680?itemId=51384232009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137744?itemId=51377442009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5527137?itemId=55271372009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20498?itemId=51385182009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138163?itemId=51381632009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20928?itemId=51383192009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137638?itemId=51376382009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137800?itemId=51378002009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137737?itemId=51377372009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20522?itemId=51384562009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20758?itemId=51384092009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20598?itemId=51383962009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5530303?itemId=55303032009-04-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20459?itemId=51385152009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137515?itemId=51375152009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137843?itemId=51378432009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/206761?itemId=55290932009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138226?itemId=51382262009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20457?itemId=51385132009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5527491?itemId=55274912009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20572?itemId=51384612009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20502?itemId=51384492009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20982?itemId=51382832009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138221?itemId=51382212009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137782?itemId=51377822009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20736?itemId=51384162009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137519?itemId=51375192009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20800?itemId=51383352009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137525?itemId=51375252009-04-06monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20756?itemId=51384332009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5526817?itemId=55268172009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137483?itemId=51374832009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20754?itemId=51384302009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20746?itemId=51384282009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138155?itemId=51381552009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137767?itemId=51377672009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20536?itemId=51384592009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20950?itemId=51382692009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137497?itemId=51374972009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5526614?itemId=55266142009-04-20monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137523?itemId=51375232009-04-15monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137629?itemId=51376292009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20964?itemId=51382882009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137495?itemId=51374952009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137643?itemId=51376432009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20678?itemId=51384142009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20455?itemId=51385242009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20796?itemId=51383312009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20574?itemId=51384822009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/18971?itemId=51383932009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137755?itemId=51377552009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137739?itemId=51377392009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137491?itemId=51374912009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137507?itemId=51375072009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137513?itemId=51375132009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138216?itemId=51382162009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20942?itemId=51382932009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20972?itemId=51382792009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20734?itemId=51384262009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137636?itemId=51376362009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20966?itemId=51383002009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/18750?itemId=51385012009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137478?itemId=51374782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20782?itemId=51383292009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137719?itemId=51377192009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137715?itemId=51377152009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137627?itemId=51376272009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20674?itemId=51383982009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20520?itemId=51384802009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137711?itemId=51377112009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20504?itemId=51384752009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137487?itemId=51374872009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20996?itemId=51381952009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20766?itemId=51383242009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20768?itemId=51383262009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137730?itemId=51377302009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20453?itemId=51385112009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20742?itemId=51384002009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137751?itemId=51377512009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20672?itemId=51384192009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20451?itemId=51385082009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20580?itemId=51384682009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20578?itemId=51384662009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20576?itemId=51384632009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20750?itemId=51384052009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20764?itemId=51384122009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20752?itemId=51384072009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20748?itemId=51384022009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20980?itemId=51382812009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137818?itemId=51378182009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20500?itemId=51385202009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137641?itemId=51376412009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20447?itemId=51385032009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20586?itemId=51384732009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138161?itemId=51381612009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20986?itemId=51383222009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137840?itemId=51378402009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20676?itemId=51384212009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20984?itemId=51382862009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20944?itemId=51382952009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20956?itemId=51382982009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137517?itemId=51375172009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137780?itemId=51377802009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20506?itemId=51384522009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137624?itemId=51376242009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20449?itemId=51385062009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137699?itemId=51376992009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137704?itemId=51377042009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137706?itemId=51377062009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137709?itemId=51377092009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137713?itemId=51377132009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137721?itemId=51377212009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137725?itemId=51377252009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137727?itemId=51377272009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137732?itemId=51377322009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137742?itemId=51377422009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137746?itemId=51377462009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137749?itemId=51377492009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137753?itemId=51377532009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137758?itemId=51377582009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137760?itemId=51377602009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137762?itemId=51377622009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137765?itemId=51377652009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137770?itemId=51377702009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137772?itemId=51377722009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137774?itemId=51377742009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137776?itemId=51377762009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137802?itemId=51378022009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137804?itemId=51378042009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137806?itemId=51378062009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137808?itemId=51378082009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137810?itemId=51378102009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137814?itemId=51378142009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137816?itemId=51378162009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137820?itemId=51378202009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137822?itemId=51378222009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137824?itemId=51378242009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137826?itemId=51378262009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137828?itemId=51378282009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137830?itemId=51378302009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137833?itemId=51378332009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137835?itemId=51378352009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137838?itemId=51378382009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20994?itemId=51381922009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/21000?itemId=51382002009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138203?itemId=51382032009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138205?itemId=51382052009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138208?itemId=51382082009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138210?itemId=51382102009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138212?itemId=51382122009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138218?itemId=51382182009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138224?itemId=51382242009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5138230?itemId=51382302009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20958?itemId=51382742009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/20960?itemId=51382762009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2008/5137702?itemId=51377022009-03-23monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/2010-01-07daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20364?itemId=51446392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19441?itemId=51463032009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20344?itemId=51447672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20024?itemId=51450662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18835?itemId=51467382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19655?itemId=51457442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20394?itemId=51446462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18847?itemId=51467492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20018?itemId=51450602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19695?itemId=51457632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19537?itemId=51458262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18825?itemId=51468292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19149?itemId=51464472009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20034?itemId=51450752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20264?itemId=51447202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20058?itemId=51450942009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19401?itemId=51462802009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19737?itemId=51457832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20006?itemId=51452372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18799?itemId=51468362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20402?itemId=51446572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18833?itemId=51468312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20050?itemId=51450842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18921?itemId=51467882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18843?itemId=51467432009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18947?itemId=51464082009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19215?itemId=51464772009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20358?itemId=51446312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20362?itemId=51446362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19916?itemId=51452392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19697?itemId=51457672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18985?itemId=51464222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20102?itemId=51451222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19403?itemId=51462832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20110?itemId=51451292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20342?itemId=51447642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19646?itemId=51457372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19976?itemId=51452282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19661?itemId=51457462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19651?itemId=51457392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18923?itemId=51467902009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19663?itemId=51457492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19328?itemId=51462642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19217?itemId=51464982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18837?itemId=51467402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20282?itemId=51447252009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20232?itemId=51447712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18941?itemId=51468042009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18933?itemId=51467992009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19233?itemId=51462402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20086?itemId=51451132009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19235?itemId=51462422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19193?itemId=51464702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19407?itemId=51462852009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20236?itemId=51447092009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20314?itemId=51447442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20162?itemId=51448222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20196?itemId=51448422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20118?itemId=51451362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20366?itemId=51446422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19541?itemId=51458282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19185?itemId=51464652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20202?itemId=51448482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20356?itemId=51446282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19318?itemId=51462622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19159?itemId=51464912009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19284?itemId=51462562009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19739?itemId=51457752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19788?itemId=51457872009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20218?itemId=51448632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19121?itemId=51464422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18789?itemId=51468342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20408?itemId=51446682009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20068?itemId=51451032009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18937?itemId=51468062009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19681?itemId=51457612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19551?itemId=51458402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20404?itemId=51446652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19741?itemId=51457852009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19671?itemId=51457812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20242?itemId=51447152009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19657?itemId=51457782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20088?itemId=51451412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20246?itemId=51447742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20280?itemId=51447762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19109?itemId=51464842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20184?itemId=51448772009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20206?itemId=51448822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20072?itemId=51451392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20100?itemId=51451462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19397?itemId=51462752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20166?itemId=51448752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19348?itemId=51463072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19457?itemId=51458212009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19113?itemId=51464862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20188?itemId=51448792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/5144784?itemId=51447842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20096?itemId=51451442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20288?itemId=51447312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20410?itemId=51446612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20032?itemId=51450722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20146?itemId=51448712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19978?itemId=51452412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20354?itemId=51446632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20334?itemId=51447812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19962?itemId=51452092009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18831?itemId=51468382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20174?itemId=51448332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19167?itemId=51464562009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19431?itemId=51462952009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20318?itemId=51447492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20360?itemId=51446332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19239?itemId=51462462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19237?itemId=51462442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18931?itemId=51467972009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18821?itemId=51468272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18854?itemId=51467552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19644?itemId=51458382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19902?itemId=51451712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20114?itemId=51451342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20348?itemId=51447692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20004?itemId=51452352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20326?itemId=51447552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19187?itemId=51464952009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19378?itemId=51462702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19095?itemId=51464282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19097?itemId=51464302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19111?itemId=51464342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19117?itemId=51464382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19147?itemId=51464452009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19153?itemId=51464492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19157?itemId=51464522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19161?itemId=51464542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19173?itemId=51464592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19179?itemId=51464612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19211?itemId=51464722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19213?itemId=51464742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19075?itemId=51464792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19107?itemId=51464822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18845?itemId=51467452009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18851?itemId=51467522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18856?itemId=51467572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18860?itemId=51467612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18862?itemId=51467632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18868?itemId=51467652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18870?itemId=51467692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18878?itemId=51467712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18895?itemId=51467742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18897?itemId=51467762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18899?itemId=51467792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18903?itemId=51467812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18913?itemId=51467832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18919?itemId=51467862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18925?itemId=51467932009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18927?itemId=51467952009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18935?itemId=51468012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20098?itemId=51451202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20104?itemId=51451242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20108?itemId=51451272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20112?itemId=51451322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19898?itemId=51451692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19904?itemId=51451742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19906?itemId=51451762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19908?itemId=51451782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19910?itemId=51451822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19912?itemId=51451842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19914?itemId=51451862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19922?itemId=51451902009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19924?itemId=51451922009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19934?itemId=51451952009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19950?itemId=51451982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19952?itemId=51452012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19958?itemId=51452032009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19960?itemId=51452072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19964?itemId=51452122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19966?itemId=51452152009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19968?itemId=51452172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19970?itemId=51452212009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19972?itemId=51452232009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19974?itemId=51452262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19982?itemId=51452302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20002?itemId=51452332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19653?itemId=51457422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19665?itemId=51457522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19667?itemId=51457542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19669?itemId=51457582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19733?itemId=51457692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19735?itemId=51457722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19449?itemId=51458152009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19451?itemId=51458172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19455?itemId=51458192009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19459?itemId=51458242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19547?itemId=51458312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19549?itemId=51458332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19608?itemId=51458352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19219?itemId=51462362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19229?itemId=51462382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19251?itemId=51462482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19255?itemId=51462502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19257?itemId=51462522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19271?itemId=51462542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19286?itemId=51462582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19316?itemId=51462602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19354?itemId=51462662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19368?itemId=51462682009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19392?itemId=51462732009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19399?itemId=51462782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19413?itemId=51462882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19417?itemId=51462912009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19419?itemId=51462932009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19433?itemId=51462972009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19437?itemId=51462992009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19447?itemId=51463052009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18943?itemId=51464052009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18967?itemId=51464112009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18969?itemId=51464142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18975?itemId=51464172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/18977?itemId=51464202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/19079?itemId=51464262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20022?itemId=51450632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20368?itemId=51446442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20396?itemId=51446492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20398?itemId=51446522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20400?itemId=51446552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20406?itemId=51446592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20234?itemId=51447072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20240?itemId=51447132009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20262?itemId=51447172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20278?itemId=51447222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20284?itemId=51447292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20290?itemId=51447352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20308?itemId=51447372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20312?itemId=51447412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20316?itemId=51447462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20322?itemId=51447532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20328?itemId=51447582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20340?itemId=51447622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20116?itemId=51448072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20128?itemId=51448092009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20130?itemId=51448112009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20154?itemId=51448142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20156?itemId=51448162009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20158?itemId=51448182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20160?itemId=51448202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20164?itemId=51448242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20168?itemId=51448262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20170?itemId=51448292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20172?itemId=51448312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20176?itemId=51448352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20190?itemId=51448372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20192?itemId=51448392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20198?itemId=51448442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20200?itemId=51448462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20208?itemId=51448502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20210?itemId=51448532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20212?itemId=51448552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20214?itemId=51448582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20216?itemId=51448602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20228?itemId=51448662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20230?itemId=51448692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20010?itemId=51450572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20030?itemId=51450692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20036?itemId=51450782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20048?itemId=51450812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20052?itemId=51450862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20054?itemId=51450882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20056?itemId=51450922009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20060?itemId=51450962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20062?itemId=51450992009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20064?itemId=51451012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20070?itemId=51451062009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20074?itemId=51451082009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20084?itemId=51451102009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20090?itemId=51451152009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2007/20092?itemId=51451172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/2010-01-07daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17792?itemId=51483742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17477?itemId=51494282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17516?itemId=51494122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/16034?itemId=51496502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18464?itemId=51472802009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18416?itemId=51476902009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17943?itemId=51481862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17540?itemId=51484192009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17121?itemId=51496222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17119?itemId=51496202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18460?itemId=51472782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18222?itemId=51477552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17211?itemId=51494802009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/16032?itemId=51496472009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17868?itemId=51481572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17506?itemId=51494302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17975?itemId=51480162009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18276?itemId=51477602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17269?itemId=51494512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18446?itemId=51476982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17205?itemId=51496312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17530?itemId=51494142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17786?itemId=51483482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17664?itemId=51484442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17680?itemId=51484472009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17163?itemId=51496572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18526?itemId=51473102009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18638?itemId=51472322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17572?itemId=51484282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18434?itemId=51476962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18634?itemId=51472632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18009?itemId=51480462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17195?itemId=51494782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18390?itemId=51476882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18344?itemId=51477512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18624?itemId=51473302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17171?itemId=51496242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17949?itemId=51481842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17217?itemId=51494862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18534?itemId=51473522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17165?itemId=51495962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18512?itemId=51473452009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17866?itemId=51481702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18740?itemId=51472512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17981?itemId=51480202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17985?itemId=51480252009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17207?itemId=51496122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17227?itemId=51494672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17275?itemId=51494722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17277?itemId=51494532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18292?itemId=51477462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17538?itemId=51484492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17654?itemId=51484622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17955?itemId=51481642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17514?itemId=51494102009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18436?itemId=51476662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18632?itemId=51472612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17826?itemId=51483762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18714?itemId=51472432009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18748?itemId=51472552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18422?itemId=51476932009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18570?itemId=51473182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/16074?itemId=51496542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17526?itemId=51494332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18742?itemId=51472532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18448?itemId=51476712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17995?itemId=51480342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18005?itemId=51480412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18007?itemId=51480442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18640?itemId=51472342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18011?itemId=51480702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17475?itemId=51494082009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17951?itemId=51481732009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17193?itemId=51496272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17300?itemId=51494182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17971?itemId=51480792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17532?itemId=51484672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17253?itemId=51494422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18055?itemId=51480812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18456?itemId=51473352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18528?itemId=51473502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17889?itemId=51481602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18348?itemId=51476762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18280?itemId=51477712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17784?itemId=51483892009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18510?itemId=51473432009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18414?itemId=51476482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17648?itemId=51484742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17864?itemId=51481792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18454?itemId=51473322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18472?itemId=51473372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17323?itemId=51494222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17458?itemId=51494262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18294?itemId=51477752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18484?itemId=51473412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18230?itemId=51477692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17840?itemId=51483812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17953?itemId=51481622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17947?itemId=51481822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17650?itemId=51484762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17203?itemId=51496292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17542?itemId=51484692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18282?itemId=51477732009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17562?itemId=51484712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18514?itemId=51473482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17225?itemId=51494952009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17852?itemId=51483832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17836?itemId=51483792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17400?itemId=51494242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18352?itemId=51476802009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18364?itemId=51476832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17967?itemId=51480762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17860?itemId=51483652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17844?itemId=51483592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17858?itemId=51483862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17223?itemId=51494932009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17652?itemId=51484782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17658?itemId=51484812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18819?itemId=51472652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17221?itemId=51494912009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/16054?itemId=51496522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18003?itemId=51480392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18428?itemId=51476572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18023?itemId=51480562009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17999?itemId=51480682009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18771?itemId=51472592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17209?itemId=51494402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17285?itemId=51494752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17265?itemId=51494492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17261?itemId=51494702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17279?itemId=51494552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18047?itemId=51480722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18769?itemId=51472572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17215?itemId=51494842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18384?itemId=51476862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18153?itemId=51477662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17219?itemId=51494892009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18708?itemId=51472362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17364?itemId=51494162009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17977?itemId=51480182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17983?itemId=51480232009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17987?itemId=51480272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17991?itemId=51480302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17993?itemId=51480322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17997?itemId=51480372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18013?itemId=51480482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18015?itemId=51480512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18017?itemId=51480532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18077?itemId=51480592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17979?itemId=51480622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17989?itemId=51480642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17961?itemId=51481672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17963?itemId=51481752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17774?itemId=51483442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17828?itemId=51483512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17832?itemId=51483542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17842?itemId=51483562009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17850?itemId=51483612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17862?itemId=51483672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17838?itemId=51483692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17846?itemId=51483722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17544?itemId=51484212009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17546?itemId=51484242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17564?itemId=51484262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17578?itemId=51484302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17598?itemId=51484332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17638?itemId=51484352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17640?itemId=51484372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17660?itemId=51484402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17662?itemId=51484422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17568?itemId=51484522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17570?itemId=51484552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17634?itemId=51484572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17642?itemId=51484602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17678?itemId=51484642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17292?itemId=51494062009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17257?itemId=51494442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17259?itemId=51494462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17281?itemId=51494572009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17283?itemId=51494602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17288?itemId=51494622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17199?itemId=51494652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17167?itemId=51495982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17173?itemId=51496012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17181?itemId=51496042009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17197?itemId=51496062009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17201?itemId=51496092009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17169?itemId=51496142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17191?itemId=51496172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18628?itemId=51472282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18630?itemId=51472302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18710?itemId=51472392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18712?itemId=51472412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18716?itemId=51472452009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18718?itemId=51472472009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18738?itemId=51472492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18458?itemId=51472762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18466?itemId=51472842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18468?itemId=51472862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18478?itemId=51472882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18486?itemId=51472902009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18494?itemId=51472922009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18496?itemId=51472942009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18498?itemId=51472962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18500?itemId=51472982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18502?itemId=51473002009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18504?itemId=51473022009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18516?itemId=51473042009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18518?itemId=51473062009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18524?itemId=51473082009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18554?itemId=51473122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18562?itemId=51473142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18564?itemId=51473162009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18572?itemId=51473202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18620?itemId=51473252009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18622?itemId=51473272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18354?itemId=51476222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18350?itemId=51476192009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18362?itemId=51476242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18386?itemId=51476262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18388?itemId=51476292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18394?itemId=51476312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18396?itemId=51476332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18400?itemId=51476362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18402?itemId=51476382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18408?itemId=51476412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18410?itemId=51476432009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18412?itemId=51476462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18418?itemId=51476502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18420?itemId=51476532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18426?itemId=51476552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18430?itemId=51476592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18432?itemId=51476632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18444?itemId=51476682009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18392?itemId=51476742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18151?itemId=51477192009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18211?itemId=51477232009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18218?itemId=51477252009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18220?itemId=51477282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18272?itemId=51477302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18274?itemId=51477322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18278?itemId=51477352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18284?itemId=51477372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18286?itemId=51477392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18288?itemId=51477432009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18308?itemId=51477482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18209?itemId=51477532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18224?itemId=51477582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18290?itemId=51477622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/18340?itemId=51477642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17965?itemId=51480112009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17973?itemId=51480142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2006/17213?itemId=51494822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/2010-01-07daily0.6http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15520?itemId=32589382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15051?itemId=32566122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15496?itemId=32589342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15710?itemId=51503042009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15306?itemId=32589152009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15580?itemId=51505722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15526?itemId=31724182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15982?itemId=51498942009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15800?itemId=51502442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15258?itemId=32589092009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15570?itemId=51505682009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15886?itemId=51499912009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15852?itemId=51499742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15722?itemId=51503072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15624?itemId=51504502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15234?itemId=32589032009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15588?itemId=51505502009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15980?itemId=51499172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15582?itemId=51505462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15922?itemId=51499052009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15926?itemId=51499072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15590?itemId=51505532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15123?itemId=31723422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15600?itemId=51505592009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15312?itemId=31723772009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15984?itemId=51499192009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15694?itemId=51502822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15962?itemId=51499142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15550?itemId=32589492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15342?itemId=32589262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15798?itemId=51502412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15902?itemId=51499662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15558?itemId=32589512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15610?itemId=51504462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15812?itemId=51499702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15736?itemId=51502112009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/8028?itemId=32562972009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15206?itemId=31723712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15504?itemId=31724062009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15170?itemId=31723612009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15338?itemId=31723892009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15346?itemId=31723932009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15606?itemId=31724512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15594?itemId=51505562009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15304?itemId=31723732009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15794?itemId=51502022009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15192?itemId=32588962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15958?itemId=51499122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15160?itemId=32588842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15330?itemId=32589222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15168?itemId=32588862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15804?itemId=51502462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15125?itemId=32566202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15190?itemId=32588942009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15990?itemId=51499212009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15618?itemId=51504482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15164?itemId=31736942009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15049?itemId=32566102009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15208?itemId=32588982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/16052?itemId=51498962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15802?itemId=51502052009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15053?itemId=31723242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15836?itemId=51499312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15604?itemId=51504202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15148?itemId=31723522009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15898?itemId=51499622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15908?itemId=51499682009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15876?itemId=51499512009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15890?itemId=51499582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15854?itemId=51499762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15103?itemId=32566162009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15188?itemId=31723692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15538?itemId=32589422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15764?itemId=51502242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15780?itemId=51502352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15758?itemId=51502202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15896?itemId=51499932009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15708?itemId=51503012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15762?itemId=51502222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15868?itemId=51499782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15134?itemId=32566222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15522?itemId=32589402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15572?itemId=51505702009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15784?itemId=51502392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15756?itemId=51502172009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15772?itemId=51502292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15738?itemId=51502132009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15824?itemId=51499722009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15930?itemId=51499102009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15770?itemId=51502272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15350?itemId=32589302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15111?itemId=32566182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15236?itemId=32589052009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15176?itemId=32588882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15260?itemId=32589112009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15332?itemId=32589242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15344?itemId=32589282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15774?itemId=51502312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15782?itemId=51502372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15546?itemId=32589472009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15370?itemId=32589322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15576?itemId=51505442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15874?itemId=51499832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15216?itemId=32589012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15242?itemId=32589072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15730?itemId=51503112009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15308?itemId=32589182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15314?itemId=32589202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15562?itemId=51505622009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15724?itemId=51503092009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15154?itemId=32588822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15584?itemId=51505752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15140?itemId=32566242009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15884?itemId=51499882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15516?itemId=32589362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15740?itemId=51502152009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15918?itemId=51498762009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15180?itemId=32588902009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15184?itemId=32588922009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/151421?itemId=32588802009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15706?itemId=51502982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15910?itemId=51499022009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15095?itemId=32566142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15544?itemId=32589442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15870?itemId=51499812009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15682?itemId=51502782009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15087?itemId=31723262009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15666?itemId=51504442009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15530?itemId=31724212009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15532?itemId=31724232009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15540?itemId=31724252009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15542?itemId=31724272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15548?itemId=31724292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15560?itemId=31724312009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15502?itemId=31738332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15322?itemId=31723832009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15334?itemId=31723852009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15340?itemId=31723912009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15390?itemId=31723972009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15494?itemId=31723992009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15500?itemId=31724012009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15318?itemId=31737582009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15320?itemId=31737662009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15336?itemId=31737842009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15354?itemId=31738082009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15158?itemId=31723542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15162?itemId=31723562009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15172?itemId=31723632009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15174?itemId=31723652009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15608?itemId=31724532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15138?itemId=31736712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15178?itemId=31737202009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15089?itemId=31723282009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15099?itemId=31723302009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15101?itemId=31723322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15107?itemId=31723342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15109?itemId=31723362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15115?itemId=31723402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15132?itemId=31723462009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15136?itemId=31723482009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15127?itemId=31736542009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15506?itemId=31724082009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15912?itemId=51498742009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15920?itemId=51498792009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15928?itemId=51498822009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15956?itemId=51498852009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15960?itemId=51498882009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15978?itemId=51498902009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15914?itemId=51498992009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15838?itemId=51499332009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15840?itemId=51499352009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15850?itemId=51499372009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15856?itemId=51499392009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15858?itemId=51499412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15860?itemId=51499432009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15862?itemId=51499452009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15866?itemId=51499472009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15872?itemId=51499492009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15882?itemId=51499532009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15888?itemId=51499552009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15892?itemId=51499602009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15900?itemId=51499642009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15880?itemId=51499862009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15734?itemId=51501982009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15806?itemId=51502072009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15668?itemId=51502672009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15672?itemId=51502692009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15676?itemId=51502712009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15678?itemId=51502732009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15680?itemId=51502752009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15684?itemId=51502802009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15704?itemId=51502852009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15714?itemId=51502892009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15718?itemId=51502912009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15726?itemId=51502942009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15728?itemId=51502962009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15602?itemId=51504182009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15612?itemId=51504222009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15614?itemId=51504252009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15616?itemId=51504272009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15620?itemId=51504292009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15642?itemId=51504322009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15656?itemId=51504342009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15658?itemId=51504362009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15660?itemId=51504382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15662?itemId=51504402009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15664?itemId=51504422009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15564?itemId=51505412009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15508?itemId=31724102009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15510?itemId=31724122009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15512?itemId=31724142009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15518?itemId=31724162009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15113?itemId=31723382009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/pressmeddelande-per-datum/2005/15712?itemId=51502872009-03-24monthly0.5http://www.astrazeneca.se/Pressrum/Presskontakter/2009-08-12daily0.8http://www.astrazeneca.se/Sjukvarden/2009-10-29daily1.0http://www.astrazeneca.se/Sjukvarden/behandlingsomraden/2009-09-03daily0.8http://www.astrazeneca.se/Sjukvarden/Varalakemedel/2009-09-28daily0.8http://www.astrazeneca.se/lakemedel/2009-10-29daily1.0http://www.astrazeneca.se/lakemedel/Patient-FASS/2009-09-28daily0.8http://www.astrazeneca.se/Vart_ansvar/2009-03-20daily1.0http://www.astrazeneca.se/Vart_ansvar/etiska_regler/2009-04-08daily0.8http://www.astrazeneca.se/Vart_ansvar/Vara_policies/2009-04-08daily0.8http://www.astrazeneca.se/Vart_ansvar/rapporter/2009-08-18daily0.8http://www.astrazeneca.se/sitemap/2008-06-27daily1.0http://www.astrazeneca.se/search/2008-12-09daily1.0http://www.astrazeneca.se/news-hidden/2009-05-19daily1.0http://www.astrazeneca.se/news-hidden/AZ_minskar_antalet_enheter?itemId=86996312010-03-04monthly0.9http://www.astrazeneca.se/news-hidden/AstraZeneca-Merck?itemId=86996202010-03-04monthly0.9http://www.astrazeneca.se/news-hidden/AstraZenecas-helarsresultat-2009?itemId=85036982010-03-02monthly0.9http://www.astrazeneca.se/news-hidden/Haiti?itemId=85037302010-03-04monthly0.9http://www.astrazeneca.se/news-hidden/Nebunette?itemId=85036852010-03-02monthly0.9http://www.astrazeneca.se/news-hidden/Nya-antibiotika?itemId=85037392010-03-04monthly0.9http://www.astrazeneca.se/news-hidden/Rigel-Pharmaceuticals?itemId=85036692010-03-04monthly0.9http://www.astrazeneca.se/news-hidden/Sommarjobb?itemId=85037452010-03-04monthly0.9http://www.astrazeneca.se/news-hidden/tillverkning-blodtrycksmedicin?itemId=85037242010-03-04monthly0.9http://www.astrazeneca.se/welcome/2010-01-11daily1.0